The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2026

Filed:

Mar. 03, 2023
Applicant:

Polaris Pharmaceuticals. Inc., San Diego, CA (US);

Inventors:

Hung-Wen Chen, Taipei City, TW;

Shaw Tsen Chen, Taipei City, TW;

Hui-Fen Liu, Taipei City, TW;

Chih-Ling Kuo, Taipei City, TW;

Chiung-Fang Shiu, Taipei City, TW;

Assignee:

POLARIS PHARMACEUTICALS, INC., San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61K 31/555 (2006.01); A61K 33/243 (2019.01); A61K 38/50 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C12N 9/78 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/513 (2013.01); A61K 31/555 (2013.01); A61K 33/243 (2019.01); C07K 16/2818 (2013.01); C12N 9/78 (2013.01); C12Y 305/03006 (2013.01);
Abstract

A method for providing a prediction as to whether a subject with a cancer exhibits a beneficial response to arginine deprivation therapy including determining the plasma level of arginine in the subject, followed by administering to the subject an arginine deprivation therapy alone or in combination with an anti-cancer agent based on the determined plasma level of arginine. According to some embodiments of the present disclosure, the anti-cancer agent is selected from the group consisting of FOLFOX, docetaxel, cisplatin, pemetrexed, pembrolizumab, and a combination thereof.


Find Patent Forward Citations

Chen, Hung-Wen. (2026). Methods for predicting response to arginine deprivation therapy based on plasma arginine levels in cancer patients (U.S. Patent No. 12569488). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12569488

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…